Introduction
The long term prognostic value of stress myocardial perfusion imaging (MPI) with single-photon emission computed-tomography (SPECT) is well established. [1] [2] [3] [4] [5] [6] Numerous studies have demonstrated that abnormal MPI predicts a multi-fold increase in the risk of major adverse cardiac events (MACE). [1] [2] [3] [4] [5] [6] Furthermore, the prognostic utility of MPI is incremental to clinical, treadmill stress test, and coronary angiography data. [7] [8] [9] The robust prognostic data, favorable diagnostic performance, and wide availability of SPECT-MPI have led to a great expansion in utilization with consequent excessive expenditure. This growth has caused increased scrutiny by regulators and payers, who have implemented various methods to reduce procedural volume. 10 The expansion of MPI utilization prompted professional societies to develop appropriate use criteria (AUC) to guide physicians on optimal use of SPECT-MPI in patient care. 11, 12 With intensifying debate regarding healthcare costs, appropriate use is increasingly emphasized by professional societies, third party payers, and accreditation agencies. [13] [14] [15] However, there has been no prospective evaluation of the impact of appropriateness of use on the prognostic value of cardiac testing, such as MPI. In this investigation we tested the hypothesis that inappropriate use limits the prognostic value of SPECT-MPI performed in a community environment.
Design and Methods
We conducted a prospective cohort-study of consecutive patients referred for office-based, clinically-indicated SPECT-MPI between August 15, 2007 and May 15, 2010 with a 2-year follow-up. A total of 22 physicians (20 primary care and 2 cardiologists) from 11 practices encompassing 12 zip codes within the Chicago metropolitan area took part in the study.
Exclusion criteria were: missing/invalid address, missing/invalid telephone or social security
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Using QPS/QGS software (Cedars-Sinai Cardiac Suite; Los Angeles, CA), MPI scans were semiquantitatively interpreted by a single expert nuclear cardiologist (RD) who was blinded to patients' clinical and outcome data. On a 17-segment model, the segmental radiotracer activity in the rest and stress scans were scored according to the standard 5-point scale (0: normal; 1: mild; 2: moderate; 3: severe; 4: absent). 21 The segmental scores within the rest and stress scans were summed to generate summed stress and rest scores (SRS, SSS), respectively. The summed difference score (SDS) was calculated from the sum of the difference scores derived from subtracting the segmental resting scores from the segmental stress scores. Quantitative poststress gated-SPECT left ventricular ejection fraction (LVEF) <50% was considered abnormal.
Normal MPI was defined on the basis of perfusion as SSS=0-3. 22 Perfusion abnormalities were further categorized, on the basis of SSS, into mild (4) (5) (6) (7) (8) , moderate (9) (10) (11) (12) (13) , and severe (>13). 22 Reversible perfusion abnormalities, signifying stress-induced myocardial ischemia, were defined as SDS 2, and further categorized on the basis of SDS, as mild (2-4), moderate (5-7), and severe (>7). 23 Given the questionable diagnostic and prognostic value of transient ischemic dilatation of the left ventricle with otherwise normal perfusion, it was not taken into account in defining abnormal MPI. 24 In order to ensure the reproducibility of the semiquantitative assessment of the perfusion data, a random sample of 151 scans (10%) were independently interpreted by two board-certified nuclear cardiologists who were blinded to the clinical and outcome data. The inter-rater interpretation agreement (normal, fixed, or reversible defect) between the main reader and the difference score (SDS) was calculated from the sum of the difference scores der riv iv ved ed d f f fro ro rom m m ubtracting the segmental resting scores from the segmental stress scores. Quantitative postt tre re ess s ss g g g t at ated ed ed-S -S -SPE E EC CT CT left ventricular ejection fract ct ctio ion n (LVEF) <50 0% % % wa wa as s s c considered abnormal.
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Outcome Determination
Subjects were prospectively followed for events of death from any cause, cardiac death, nonfatal MI, coronary angiography, percutaneous coronary intervention (PCI), and coronary artery bypass-graft surgery (CABG). Outcome assessors were blinded to MPI findings and AUC classification. Four methods for ascertaining outcome events were uniformly applied: 1) review of patient health records (from July 2011 through February 2012) at the referring physician offices; 2) two identical questionnaires mailed to patient residences 6 months apart (July 2011
and January 2012); 3) telephone interviews for subjects who did not complete mail surveys; and 4) Social Security Death Index search (April 2012) with cause of death determined from death certificates. MI events were defined by the clinical determination of the treating cardiologist.
Fatal MIs were considered cardiac deaths if death occurred within the same hospitalization.
Social Security Death Index return was used to discern the date of death and determine follow-up time for pure mortality endpoints (death and cardiac death). The follow-up time for the composite endpoints (death or MI and cardiac death or MI) and coronary interventions was determined based on the last clinical encounter date as determined by surveys, phone interviews, or medical records. Revascularization procedures performed within 60 days following MPI were considered to be triggered by MPI findings, whereas those occurring late (>60 days) were considered to be prompted by clinical deterioration or poor response to medical therapy.
The primary endpoint was all-cause mortality. Secondary endpoints were: 1) composite endpoint of death or MI; 2) composite endpoint of cardiac death or MI.
Statistical Analysis
Based on published preliminary data, we predicted an abnormal MPI rate of 12%. 25 Fa ata ta al l l MI MI MIs s we w w r re c c con on onsi s dered cardiac deaths if dea ath th th o o occurred withi in n n the e sa sa sam me hospitalization.
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The chi-square test was used to compare dichotomous variables, which were expressed as frequency (percentage). The Fisher's exact test was used for dichotomous comparisons when the number of events was 5. The 2-tailed Student's t-test was used to compare normallydistributed continuous variables which were expressed as mean ± standard deviation (SD). A multivariable logistic regression model was used to determine the independent predictors of early (<60 days) coronary revascularization events. The correlation coefficient (r) between skewed continuous variables was determined using Spearman's method. Cox proportional-hazards models were used to compare hazards adjusted for covariates. The clinical covariates adjusted for were: age, gender, diabetes mellitus, hypertension, dyslipidemia, tobacco use, known CAD (prior MI, CABG, or PCI), and stress modality. Proportionality of hazards assumption was confirmed by demonstrating parallel "log minus log" survival plots.
Stepwise Cox-regression models were used to evaluate the gain in the global chi-square value and, hence, the predictive value of clinical and imaging predictors. Two-tailed P values <0.05 were considered significant.
The PASW 18.0 software (SPSS, Inc. -Chicago, IL) was used for statistical analyses.
The study was approved by the institutional review board of Rush University Medical frequency (percentage). The Fisher's exact test was used for dichotomous compa a ari r riso so s ns ns s w w whe he hen n n t the number of events was 5. The 2-tailed Student's t-test was used to compare normallydi ist st tri ri ribu bu but te ted d d co co contin in nu uo uous variables which were expr pr pres essed as mean ± ± st s an nda da dar rd deviation (SD). A m mul lt ltivariable lo log gi g s s stic ic r reg eg gre re ress ss sio io ion n mo mo mode del w was us sed t to o de e ete te erm rmin ine e th th he in inde de depe pe end nd den en ent t pr pr red ed edic ic icto to ors rs s o of f f e ea arly < <60 60 60 d d day ay ays) s) s) c c co or oron on nar ar ry y r re ev va vasc scul ul ular ariz iz izat at atio io ion n ev ev ven en ent t ts. Th Th T e e e c c cor rr rrel el lat at ati io ion n n co co oef f ffi fi fici cie en ent t t ( (r r) ) ) be be betw tw wee ee en s sk ske ew ewe ed ed Center. A HIPAA waiver was applied to the chart review aspect of the methods. Subjects had the right to decline participation in the study via the mailed questionnaire.
Results
We identified 1707 consecutive subjects referred for an office-based, one-day, rest/stress, Tc99m sestamibi SPECT-MPI study. MP MP PI I I r re refe ferr rra al als s we we were re f fo ou ound nd nd t t to o o be be a app pp ppro ro ropr pr pria ia i t te te in in i 7 7 779 79 79 ( ( (51 51 51.6 .6 .6% %) %), , in in ina ap appr pr prop op pri ri iat at a e e in in in 68 8 88 ( ( (45 45. . .5% % %) and uncertain n in in in 4 4 44 4 4 (2 (2 (2.9 .9 .9%) %) ) s s stu tu tudi di die e es. s. s A A All l l s s sub ub ubje je ject ct cts s s we we were re e cla la ass ss ssif if ifi i iab ab ble le le acc cc ccor or ordi di ding ng ng t to o o th th he e e 20 20 2009 0 AUC. One-hundred sixty-seven (11%) subjects had myocardial perfusion defects ( Table-1 ).
Patients in the Appropriate/Uncertain group had significantly higher rates of abnormal MPI, more severe perfusion abnormalities (SSS), and greater ischemic burden (SDS); while the breakdown of perfusion abnormality type (fixed, reversible, or mixed) was not significantly different from those in the Inappropriate group (Table 1) .
Compared to subjects with complete follow-up, the patients excluded (n=182) or lost to 
Coronary Angiography and Revascularization
During follow-up 106 (7.0%) subjects underwent one or more coronary angiography, with subsequent 61 (4.0%) PCI and 14 (0.9%) CABG ( Table 2) Patients with stress induced ischemia (SDS 2) had significantly higher rates of coronary angiography and revascularization than those with no ischemia, irrespective of appropriateness group (Table- 2) and the rates of coronary angiography and revascularization were commensurate with the myocardial ischemia burden (SDS) after adjusting for clinical covariates ( Figure-1A and 1B) . Notably, mild degree of myocardial ischemia (SDS=2-4) was associated with significant increase in the rates of coronary angiography and revascularization ( Figure-1A and 1B).
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of no significant CAD, single-or two-vessel disease, and multi-vessel or left main disease ( Figure-2A ).
During the entire follow-up, the median durations of time-to-angiography and time-torevascularization in patients with myocardial ischemia were shorter in the inappropriate use group (0.8 vs. 1.7 months and 0.6 vs. 1.3 months), but these differences were not statistically significant (P=0. 16 Patients with abnormal MPI had higher rates of all-cause mortality, and cardiac death, as well as secondary composite endpoints of death or MI and cardiac death or MI (Table-2 w wor rd rds, physici cian an ns wi wi ith th t h h hig ig ighe he her r r in inap ap app pr pro op pr r riate e u u use r ra at te es we we were re as ss ssoc oc cia a ate ted d d wi wi with h s s sho h hort rter er er t t tim im ime e to to to co oro ro rona na nary ry ry i int nt nte er erve vent ntio ion ns s. 
ly). ). ).
A Cox x re re egr r res ssi si s on n n-m -m mod od odel el d d dem em emo on ns s strat te ed d d tha a at i ina app pp ppro ropr pr pria iate te e M M MPI PI u u us se e w w was as a a n n neg eg gat ativ 
Discussion
This study represents the first large prospective evaluation of appropriate use of SPECT-MPI regarding its prognostic value in a patient population with known or suspected ischemic heart disease. The patient population and healthcare providers in this study represent typical community-based practices within a major metropolitan area. The study demonstrates higher inappropriate use rates than most previous reports (10 to 24%), particularly among primary care physicians (47%). 13, [26] [27] [28] [29] However, the majority of previously published data were based on single tertiary-care center experiences, in which higher-risk populations, greater AUC awareness, less prominent self-referral bias, publication bias and historic context can explain this disparity.
Moreover, there were few referrals with uncertain appropriateness in this community-based cohort, probably due to the low complexity level of the clinical presentations (chest pain, dyspnea, asymptomatic, etc.), for which the 2009 AUC document has decisive recommendations.
Of note, the majority of the MPI scans evaluated were performed before the publication and wide-scale adoption of the 2009 AUC. Hence, this study was not intended to be a report on current appropriate use rates, but rather to investigate the impact of appropriateness of use on the prognostic value of MPI.
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Moreover, th her er ere e e we we were re r f few e e r r ref ef fer erra ra rals ls l w w wit t th h h un un unce ce cer r rta ta ain in n a app pp ppro ro opr pr pria ia iate te tene ne ness s s ased i i in n n th th this is is c c com om ommu mu muni ni nity ty ty-b -ased angiography and revascularization decisions, while SSS is the better predictor for MACE events.
Furthermore, in the overall study cohort revascularization and MACE rates were commensurate with the severity of myocardial ischemia (SDS) and perfusion abnormality (SSS), respectively. Notably, abnormal MPI was associated with similarly high rates of coronary angiography and revascularization, irrespective of appropriateness. This is not surprising, as the decision-making process for coronary angiography and revascularization following abnormal MPI often does not take into account the initial appropriateness for MPI. However, when the study population was stratified based on AUC, the value of abnormal MPI in predicting MACE in the inappropriate use group was significantly diminished. Conversely, the prognostic value of MPI was maintained or slightly enhanced in the Appropriate/Uncertain group. Moreover, the study demonstrates that appropriate use provides incremental prognostic value, beyond myocardial perfusion and LVEF.
However, early coronary revascularization following MPI did not provide additional protective or predictive value (Figure-4) .
It is clear from our analyses that ischemic burden (SDS) was an independent determinant of the decision for early revascularization irrespective of appropriateness group. Furthermore, the time-to-coronary intervention analyses ( Figure- 2) reveal that patients in the Inappropriate group were referred sooner for coronary angiography and revascularization despite the low clinical risk, perhaps with little time to evaluate response to medical therapy. Our analysis also indicates that physicians with a low threshold for MPI testing tended to have a low threshold for coronary evaluation following an abnormal MPI, suggesting a non-discriminative approach to MPI findings. It is plausible that early coronary interventions are responsible for the lower event rates observed in the inappropriate use group. Nonetheless, this would be contradictory to the findings of the COURAGE trial which demonstrated that an initial revascularization strategy does not or slightly enhanced in the Appropriate/Uncertain group. Moreover, the study de emo mo mons nstr tr rat at ates es es t tha hat appropriate use provides incremental prognostic value, beyond myocardial perfusion and LVEF.
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It It i is s s cl cl c ea ear r r fr fr from om m o o our ur an na naly ly lyse se ses s s th tha a at i i isc sc sch h hem mi mic c b bu ur u d de den n n (S (S (SDS DS DS) ) wa wa as s s an an n i i ind ndep ep epen en ende de en nt nt d de e ete er ermi mi ina a ant n of the decisio on n n fo fo f r r r ea ea e rl rl rly y y re eva va vasc s s ul ul ular ar a iz iz zat atio io ion n n ir ir rre re resp sp spec ec e ti ti t ve ve v o o of f f ap ap appr pr p op op opri r r at at ten en enes es ess s s gr gr grou ou up. p. p. F F Fur ur urth th t ermore, th he by guest on August 17, 2017 http://circ.ahajournals.org/ Downloaded from improve the outcome of patients with stable CAD. 30 This investigation was not intended to be powered to detect differences in MACE rates on the basis of MPI finding within either appropriateness subgroup. However, it was designed and powered to detect incremental prognostic value with appropriate MPI use. This incremental risk prediction attained with appropriate use enhanced the excellent prognostic value of MPI in the Appropriate/Uncertain group; whereas inappropriate use was detrimental to the predictive value of MPI. This phenomenon is unlikely to be due to an interaction between appropriateness and MPI finding, as formal statistical interaction analyses were clearly negative. Nonetheless, the incremental prognostic value of appropriate use is not surprising since robust clinical predictors such as Framingham CHD risk, likelihood of CAD, and ability to exercise are major determinants of appropriateness. 12 Thus, the low event-rate observed in the inappropriate use group rendered MPI less effective in risk stratifying these already low-risk patients. It is likely that in a larger inappropriate use cohort a "statistically significant" difference in MACE rate based on MPI findings could be identified. However, the absolute difference in MACE rate would be very small and, thus, clinically insignificant.
Additionally, the downstream coronary angiography and revascularization procedures following inappropriate testing would increase cost without clear benefit. Therefore, the economic consequences of inappropriate use of SPECT-MPI are significant; considering that an approximate 5.8 million MPI studies are performed annually in the United States, nearly 85% of which are performed in the outpatient setting, 31, 32 at a cost ranging from $800 to $1000 per study according to 2013 Medicare reimbursement schedule. 33 Thus, although MPI is considered costeffective overall, 34 the diminished prognostic value with inappropriate testing could have serious implications on the overall cost-effectiveness of MPI, not to mention unnecessary radiation uch as Framingham CHD risk, likelihood of CAD, and ability to exercise are m ma aj ajor or or determinants of appropriateness. 12 Thus, the low event-rate observed in the inappropriate use gr grou ou up p p r re rend nd nder er e e e ed M M MP PI PI less effective in risk stratify fy yin in i g g g these already y y low-w--ri ri ris sk patients. It is likely h h hat t t i in a larger r i i in na nap pp ppro ro opr pr ria ia iate te te u u use se c c coh oh ho or rt a a "s sta tat tisti ic ca a ally y s sig ign n nifi fi ica can n nt" " " di diff ff ffer r ren ence ce ce i in n MA MA MACE CE C r r rat ate e e ba ase se sed d d on on o M M MPI PI PI f fin in nd di ding ng gs s c co coul u d d d be be e i i ide de den nt ntif if fie e ed. d d. H H How ow owe ev ve e er, r, t t the he e a a ab bs bsol ol olut ut te di di diff ffe e ere en ence ce e i i in n n MA MA MACE CE E r r rat ate e would be ver ry y y sm sm smal al all l l an an and, d, d t t thu hu hus, s s cl cl clin in i ic ic ical lly ly ly i i ins ns nsig ig gni ni n fi fi fica ca c nt nt n .
exposure. In fact, minimizing inappropriate use is probably the best and most cost-efficient way to limit the radiation exposure in the community.
This investigation represents the first community-based validation of the AUC for MPI. It reveals surprisingly high levels of inappropriate use with a wide-range of disparity between practitioners. The study confirms that patients with appropriate indications receive excellent risk stratification with MPI, whereas those with inappropriate indications receive limited or ineffective risk stratification at high cost and unnecessary radiation exposure. Additionally, this study further emphasizes the role of AUC as an important quality measure in the laboratory accreditation process. 15 Furthermore, it stresses the need for national organizations of primary care and cardiology to educate their members about the AUC.
This study is limited by AUC determination using chart review. However, this method has been used in many other reports. [26] [27] [28] [29] A prospective AUC determination may introduce a different bias: in addition to the bias inherent in using preselected practices and physicians with higher awareness of AUC than is commonplace, physicians' mindfulness of them being "scored"
for AUC adherence could artificially lower inappropriate use. 13 Additionally, this investigation was designed as an outcome study. Thus, detailed coronary angiography findings were not collected. Furthermore, significant number of patients were either excluded from the study [182 (12%)] or lost to follow-up [14 (0.9%)]. Nonetheless, we demonstrated that the clinical, AUC, and imaging characteristics of these patients were similar to those who underwent final analysis.
Therefore, it is unlikely for the excluded patients to change the conclusions of the investigation.
Finally, the study findings cannot be generalized to patient populations not well represented in this cohort, such as individuals presenting with acute coronary syndrome, preoperative assessment, syncope, cardiac dysrhythmias or high-risk tertiary care patients.
care and cardiology to educate their members about the AUC.
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Conclusion
This community-based prospective study demonstrates that the inappropriate use of SPECT-MPI severely impairs its value for risk assessment of patients with known or suspected ischemic heart disease; negatively impacting cost-effectiveness and radiation exposure. However, when performed for appropriate indications, SPECT-MPI maintains its robust prognostic value, even in contemporary community-based settings. This report describes the first prognostic validation of AUC for SPECT-MPI, thus solidifying their role in clinical practice, policy-making, and reimbursement decisions.
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